Guadeloupe Technology Digest
SEE OTHER BRANDS

Daily news on science and technology in Guadeloupe

Guadeloupe Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guadeloupe Technology Digest.

Press releases published on June 30, 2025

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities

SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …

COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and …

Shoals Technologies Group, Inc. Announces Battery Energy Storage Systems (“BESS”) Webinar

Shoals Technologies Group, Inc. Announces Battery Energy Storage Systems (“BESS”) Webinar

PORTLAND, Tenn., June 30, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a global leader in electrical balance of systems (“EBOS”) solutions for the energy transition market, announced today that it has …

Acesis Biomed Secures Patents Advancing Testosterone-Inducing Drug Development

Acesis Biomed Secures Patents Advancing Testosterone-Inducing Drug Development

Centennial, Colorado, June 30, 2025 (GLOBE NEWSWIRE) -- Acesis Holdings Corporation (“Acesis Biomed”), a pre-clinical stage biomedical company pioneering oral treatments for metabolic and endocrine disorders linked to low testosterone, today announced a …

Avicanna Announces Results of Annual General Meeting

Avicanna Announces Results of Annual General Meeting

TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …

Aptose Announces Deferral of Interest Payment

Aptose Announces Deferral of Interest Payment

SAN DIEGO and TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …

Earn Up to $1,000,000 a Day with BTC Miner – 100% Guaranteed Profits

Earn Up to $1,000,000 a Day with BTC Miner – 100% Guaranteed Profits

New York City, NY, June 30, 2025 (GLOBE NEWSWIRE) -- Amid ongoing market volatility in the cryptocurrency sector, investors are increasingly turning to platforms that offer greater stability and predictable returns. BTC Miner has emerged as a game-changing …

BTC Miner Cloud Mining: A Million-Dollar Opportunity Amid Crypto Market Turbulence

BTC Miner Cloud Mining: A Million-Dollar Opportunity Amid Crypto Market Turbulence

New York City, NY, June 30, 2025 (GLOBE NEWSWIRE) -- The global crypto market continues to sway between volatility and opportunity. Bitcoin has broken through key resistance levels several times in the past month, only to swiftly retrace. Ethereum is …

SunnyMining passes official certification and launches global free cloud mining reward program

SunnyMining passes official certification and launches global free cloud mining reward program

Manchester, United Kingdom, June 30, 2025 (GLOBE NEWSWIRE) -- SunnyMining, a world-renowned cloud mining platform, recently passed the authoritative official certification and officially announced the launch of the global "Free Cloud Mining Reward Program …

DataGrail Report: Consumer Demand for Data Privacy Surges, Driving Up Business Costs as Data Deletion Requests Rise

DataGrail Report: Consumer Demand for Data Privacy Surges, Driving Up Business Costs as Data Deletion Requests Rise

SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- Consumers are reclaiming control of their personal data—and businesses are feeling the impact. DataGrail’s newly released 2025 Data Privacy Trends Report shows a surge in data deletion and do not share …

Mensa IQ Test - Free International Mensa IQ Quiz with Instant Results Now Offered by QuickIQTest.org

Mensa IQ Test - Free International Mensa IQ Quiz with Instant Results Now Offered by QuickIQTest.org

New York City, June 30, 2025 (GLOBE NEWSWIRE) --  QuickIQTest.org, a trusted leader in online cognitive assessments, proudly announces the official launch of its Free Mensa IQ Test 2025. Designed to closely mirror the structure and rigor of a Mensa …

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-treat cancers, reported today that Pyxis Oncology’s …

GoHealth Secures Amended Credit Agreement Highlighting Broad Based Support from Stakeholders

GoHealth Secures Amended Credit Agreement Highlighting Broad Based Support from Stakeholders

CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace, today announced it has entered into an amendment with its lenders under the Company’s existing credit agreement in order to, among other …

Progress Software Announces Second Quarter 2025 Financial Results

Progress Software Announces Second Quarter 2025 Financial Results

Annualized Recurring Revenue ("ARR") of $838 million Grew 46% year-over-year Revenue of $237 million Grew 36% year-over-year Raises Full Year Guidance for Revenue, Operating Margin, Earnings Per Share, and Cash Flow Acquires Agentic RAG AI Company …

Progress Software Acquires Nuclia, an Innovator in Agentic RAG AI Technology

Progress Software Acquires Nuclia, an Innovator in Agentic RAG AI Technology

Company adds easy-to-use agentic RAG-as-a-service product for organizations to automate and retrieve verifiable, high-quality AI search and generative answers BURLINGTON, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Progress Software (Nasdaq: PRGS), the …

INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Boca Raton, Florida, June 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has closed its registered direct offering, announced on June 27, 2025, (the …

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has …

Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation

Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation

As of June 30th, 16 participants have enrolled in the Phase 1b, ahead of the original goal of at least 15 total participants by 3Q 2025 Analysis of 90-day biomarker activity from cerebrospinal fluid (CSF) in all participants currently enrolled is now …

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline

Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both biochemical and symptom control with a well-tolerated safety profile in patients switching treatments and those not previously …

Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital

Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital

- $100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service